FDAnews Device Daily Bulletin

Checkpoint Surgical Secures $7.5M in Financing

Dec. 21, 2015

Cleveland-based Checkpoint Surgical has secured a $7.5 million round of financing to support the growth of the company’s portfolio for orthopedic, head and neck procedures, as well as an expansion into new procedure markets.

The financing was led by growth-equity investor First Analysis, with the NDI Healthcare Fund and others also participating.

Checkpoint has two FDA cleared devices: the Checkpoint Stimulator/Locator and the Checkpoint Head and Neck Stimulator. — Michael Cipriano